A Small and Comical Pump-and-Dump

We think this company may be the most comically obvious stock promote we’ve ever seen. At IPO, the company admitted they had 1) no products, customers, or revenue, 2) but were developing an innovative sounding, ESG-oriented, “MedTech but-also-any-tech” solution with no existing patents, pending patents, or demonstrated ability to realize useful technology, and 3) was backed by multiple SEC-restricted stock promoters with histories of pump-and-dumps. The company combines almost no R&D spend with a mysterious South African facility that does not seem to be doing much of anything. In our view, the warning sirens and flashing red lights around this company render it wholly un-investable.